Clinical Trials Sponsored by Nichol Pharma Services Ltd.

Total 33 results

Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Drug Drug Interaction Study for EYP001 With Entecavir

Hepatitis B, Chronic

Australia
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects

Hepatitis B, Chronic

Thailand, Netherlands, Australia, Poland
Diurnal Limited
Simbec Research; Brush Clinical Research Ltd.; Voet Consulting; Medical Matters... and other collaborators

Completed

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Adrenal Insufficiency

United Kingdom
Mediforum Ltd., Co.
LSK Global Pharma Services Co. Ltd.

Recruiting

A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease (PM012-2b)

Mild Alzheimer Disease

Korea, Republic of
Faes Farma, S.A.
Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical... and other collaborators

Completed

Human Mass Balance Study With Bilastine

Healthy

United Kingdom
Bionomics Limited
CPR Pharma Services Pty Ltd, Australia

Terminated

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Australia
Spero Therapeutics
CPR Pharma Services Pty Ltd, Australia

Completed

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers

Healthy Volunteers

Australia
Spero Therapeutics
CPR Pharma Services Pty Ltd, Australia

Completed

Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994

Healthy Volunteers

Australia
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers

Malaria, Falciparum

Australia
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™

Malaria, Falciparum

Australia
Celtaxsys, Inc.
Linear Clinical Research; CPR Pharma Services Pty Ltd, Australia; Clinical Network...

Completed

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

Pulmonary Inflammation

Australia
Seoul National University Hospital
Green Cross Corporation; LSK Global Pharma Services Co. Ltd.

Completed

Efficacy and Safety of Anthrax Vaccine, GC1109

Anthrax

Korea, Republic of
eXIthera Pharmaceuticals
Syneos Health; CPR Pharma Services Pty Ltd, Australia; IDT CMAX Clinical Trials

Completed

Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects

Arthroplasty, Replacement, Knee

Australia
Micell Technologies
Hefei Life Science Medical Instruments Co. Ltd.; Giant Med-Pharma Services... and other collaborators

Unknown

Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) (DESSOLVE-C)

Coronary Heart Disease

China
Nova Laboratories Limited
Syne Qua Non Limited; Medicines Evaluation Unit Ltd; Alderley Analytical Ltd; Black... and other collaborators

Completed

Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®) (AZA)

Therapeutic Equivalency

United Kingdom
Galmed Pharmaceuticals Ltd
Hammersmith Medicines Research; Diamond Pharma Services Regulatory Affairs... and other collaborators

Completed

Comparison of Aramchol Concentrations With Once or Twice Daily Dosing

Healthy

United Kingdom
Tangent Data
Stanley Medical Research Institute; MediStat Ltd.; PCI pharma services (formerly... and other collaborators

Unknown

Estradiol as add-on to Antipsychotics (EST-S-02)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

Moldova, Republic of
Galmed Pharmaceuticals Ltd
Hammersmith Medicines Research; Diamond Pharma Services Regulatory Affairs... and other collaborators

Completed

Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers

Healthy

United Kingdom
U.S. Army Medical Research and Development Command
Uniformed Services University of the Health Sciences; Meiji Seika Pharma Co...

No longer available

Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria

Infection Due to Resistant Organism

United States
Galmed Pharmaceuticals Ltd
Kramer Consulting, LLC; WCCT Global; Diamond Pharma Services Regulatory Affairs... and other collaborators

Completed

Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers

Healthy Volunteers

United States
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (OZ/DSMCombo)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; Queensland Institute...

Terminated

A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (DSMOZ-2)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

SJ733 Induced Blood Stage Malaria Challenge Study (SJ733IBSMCS)

Plasmodium Falciparum Malaria

Australia
Yung Shin Pharm. Ind. Co., Ltd.
National Cheng-Kung University Hospital; Tri-Service General Hospital; Taichung...

Completed

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Squamous Cell Carcinoma of the Head and Neck | Nonsmall Cell Lung Cancer
Galmed Research and Development, Ltd.
Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaborators

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH (Aramchol_005)

Liver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver Fibroses

United States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer... and other collaborators

Completed

Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent (OZGAM)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer... and other collaborators

Completed

Experimental Falciparum Transmission to Anopheles (EFITA)

Malaria

Australia
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaborators

Completed

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique (PERSIST)

Assisted Reproductive Techniques | Reproductive Technology, Assisted

Italy, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; Right to Care and other collaborators

Recruiting

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. (Sisonke Boost)

SARS CoV 2 Infection

South Africa

Clinical Trials Sponsored by Nichol Pharma Services Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations